Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes
about
The endocannabinoid system as an emerging target of pharmacotherapyEndogenous and Synthetic Cannabinoids as Therapeutics in Retinal DiseaseThe Endocannabinoid System in the Retina: From Physiology to Practical and Therapeutic ApplicationsNeuroinflammatory responses in diabetic retinopathyAnti-inflammatory strategies in cartilage repairIs the cardiovascular system a therapeutic target for cannabidiol?Protective effects of cannabidiol on lesion-induced intervertebral disc degenerationNa+/H+-exchanger-1 inhibition counteracts diabetic cataract formation and retinal oxidative-nitrative stress and apoptosisAnandamide improves the impaired nitric oxide-mediated neurogenic relaxation of the corpus cavernosum in diabetic rats: involvement of cannabinoid CB1 and vanilloid VR1 receptorsCalcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetesCannabidiol As a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development.Ligation of CD40 in Human Müller Cells Induces P2X7 Receptor-Dependent Death of Retinal Endothelial Cells.Diabetic retinopathy: current management and experimental therapeutic targets.Reduced nitro-oxidative stress and neural cell death suggests a protective role for microglial cells in TNFalpha-/- mice in ischemic retinopathy.Adaptive cerebral neovascularization in a model of type 2 diabetes: relevance to focal cerebral ischemia.Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy.Targeting cannabinoid signaling for peritoneal dialysis-induced oxidative stress and fibrosis.Cannabinoids as novel anti-inflammatory drugs.Correlation Between Cannabidiol-Induced Reduction of Infarct Volume and Inflammatory Factors Expression in Ischemic Stroke Model.Effect of intravitreal injection of ranibizumab on retinal ganglion cells and microvessels in the early stage of diabetic retinopathy in rats with streptozotocin-induced diabetesA single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study.Cannabidiol protects retinal neurons by preserving glutamine synthetase activity in diabetes.Physiological effects of superoxide dismutase on altered visual function of retinal ganglion cells in db/db miceCannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far.Cannabinoid control of neuroinflammation related to multiple sclerosis.Evaluation of the aldose reductase inhibitor fidarestat on ischemia-reperfusion injury in rat retina.The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy.A(₂A) adenosine receptor (A(₂A)AR) as a therapeutic target in diabetic retinopathy.Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.Diabetes-induced superoxide anion and breakdown of the blood-retinal barrier: role of the VEGF/uPAR pathway.Diabetes and retinal vascular dysfunction.Edaravone protect against retinal damage in streptozotocin-induced diabetic mice.Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice.Metformin treatment in the period after stroke prevents nitrative stress and restores angiogenic signaling in the brain in diabetes.Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complicationsCannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activationCerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes.Decrease in retinal neuronal cells in streptozotocin-induced diabetic mice.
P2860
Q24648473-35399C68-6D28-46C0-B47B-DA94B9A3F2FAQ26765576-875F05C0-4B9A-4E74-BD3E-FAF975F81206Q26765747-3031CC4B-67EA-4A7D-B6B9-38054654A76EQ26798351-E72C10B5-6E69-4AF9-988A-08662E54F29DQ26862600-3FB54CA6-A5D4-4569-A792-0DD363885CCAQ26865370-C889E253-8B48-47C9-93CC-2C410A43926BQ28542740-4085702D-A560-4467-94F7-9AAF99261F0BQ28581192-AB8D4A0A-44A2-4923-8D25-0C27D427A774Q28581593-972D00CC-6E95-444B-9167-192DBE3748C2Q28584295-7246EBB4-0F1D-4681-851C-621D99E3C710Q30497010-AB99E2DE-D7B4-4294-9C4A-BDE8A1BCD55BQ32185814-5A4D9D0A-49F3-47E9-816B-28FF264BE53EQ33403016-C924F249-16D7-4E03-A4D8-A99CC742B665Q33526952-C4A7D07D-BFA0-4D12-BCFC-23A9C413980EQ33556549-57D62FBA-0B90-4C84-8B75-78D5F99F174FQ33641986-131AB25D-A720-44F9-8D02-8A46CC92BB5AQ33655394-4A93C3DB-6D6C-4A0F-8DD8-9459F43D0566Q33688381-2635261A-D89B-4B10-9553-840DD6D9E675Q33716712-ED31FF36-F4CF-4868-95A4-7AFE1AC78290Q33744652-3B9D7060-FDBB-4170-8DC3-EBC88419BAA7Q33798050-3F34ABF0-2580-4287-BA28-339253B2B2D5Q34079326-A3ADA34D-513E-448C-B3F1-73362043438AQ34137707-951101C5-1D91-480E-89BE-BFFD8588D205Q34519365-168431DD-8A50-4B37-817D-0B0C42EE9639Q34545203-EAA15000-13B4-4333-94C8-BA35BB56173CQ34583231-24554373-B4A6-43DB-949C-2E224E50F376Q34603008-659B7AAD-2806-4BAB-B472-F2B715018A04Q34645612-2BD1A053-19A8-4CFD-9EF3-77E024F38D8BQ34838463-6BBF54C6-7A94-424E-8F3C-034F1D0BA1AFQ34898890-4AF64D2E-A964-4E16-9137-4882BCF33AFFQ34950799-805374FE-2D6D-4028-8560-0DBE8F54D600Q35017752-8BFE8C7E-B1DA-4661-A77C-E8CA3347FB3DQ35181567-63478727-B8A1-4402-A7C9-E7EE1CA5490CQ35193309-5160AB56-F569-46FF-8DA9-9F777220DF5FQ35532277-CB5D8A8F-EBCA-4F35-BA68-DE8486BD218FQ35613040-C65C1756-FEFC-47A6-B9B7-63F4BE1C3209Q35951992-2F77F8B7-0BF5-4CF7-8452-9EE5355CF479Q35966006-06257879-02DA-4991-85DA-8D4CA8F772D6Q35994979-93BE74AD-D5D9-4E6A-A2AD-0F853C280FA8Q36015795-A4F2ADB4-00E0-43F7-A1CF-8F29BEFCF696
P2860
Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Neuroprotective and blood-reti ...... idiol in experimental diabetes
@ast
Neuroprotective and blood-reti ...... idiol in experimental diabetes
@en
type
label
Neuroprotective and blood-reti ...... idiol in experimental diabetes
@ast
Neuroprotective and blood-reti ...... idiol in experimental diabetes
@en
prefLabel
Neuroprotective and blood-reti ...... idiol in experimental diabetes
@ast
Neuroprotective and blood-reti ...... idiol in experimental diabetes
@en
P2093
P2860
P50
P1476
Neuroprotective and blood-reti ...... idiol in experimental diabetes
@en
P2093
Gregory I Liou
Nai-Tse Tsai
Yousuf Khalifa
P2860
P304
P356
10.2353/AJPATH.2006.050500
P407
P577
2006-01-01T00:00:00Z